ACN vs GIB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: GIB is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and GIB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and GIB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

CGI Inc. is one of the largest independent information-technology and business-consulting firms in the world, founded in 1976 in Montreal and now employing roughly 94,000 people across the Americas, Europe, and Asia-Pacific. It provides IT and business-process services spanning strategic consulting, systems integration (including AI, cloud, data, and legacy modernization), managed IT and business-process outsourcing, and application services. Roughly half of revenue comes from long-term managed-services contracts and half from consulting and systems integration, split across government, financial services, health, manufacturing, retail, energy, and telecom clients. CGI reports its financials in Canadian dollars, so the US-listed GIB shares carry currency translation on top of the underlying business.

Full GIB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• GIB drivers: Backlog and recurring managed services; Build-and-buy acquisition model.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For GIB, organic growth is modest (low single digits), so much of CGI's expansion depends on continuing to find and integrate sizeable acquisitions, which carries execution and pricing risk.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; GIB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and GIB guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

GIB. CGI reports in Canadian dollars while GIB trades in US dollars on the NYSE, so headline figures and the share price are in different currencies. The company delivered mid-single-digit revenue growth and high-single-digit to double-digit EPS growth into fiscal 2026, backed by an 11.8% adjusted margin and a backlog near two times revenue. GIB traded around the mid-$60s in mid-2026, down roughly 28% year to date, leaving valuation multiples below the firm's historical range.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); GIB shows revenue (ttm) ~$16 billion CAD (~C$16B), adjusted diluted eps (fy2025) ~$8.30 CAD, up ~9% YoY, q2 fy2026 revenue ~$4.16 billion CAD, up ~3.3% YoY, backlog ~$31 billion CAD (~2.0x annual revenue).

ACN and GIB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and GIB exposure against your real portfolio. It is not an investment adviser.